MSLPQ — MusclePharm Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for MusclePharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11 | -10.8 | -18.9 | 3.19 | -12.9 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.22 | 2.19 | 1.33 | -1.16 | 2.72 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.161 | 9.7 | 10.4 | -3.36 | 1.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.13 | 1.98 | -6.52 | -0.868 | -8.04 |
| Capital Expenditures | -0.037 | -0.132 | -0.013 | -0.004 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | 0.222 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.037 | -0.132 | -0.013 | 0.218 | -0.002 |
| Financing Cash Flow Items | — | — | — | — | -0.848 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.44 | -5.73 | 5.74 | 1.12 | 7.26 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.28 | -3.91 | -0.785 | 0.471 | -0.78 |